Melissa Blann, MD
Anatomic Pathology & Clinical Pathology · Lubbock, TXNPI 1396725446
Payments from drug & device makers
Across 25 payments — averaging $38.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Siemens Medical Solutions USA, Inc.$520
- Abbott$149
- Daiichi Sankyo Inc.$123
- Genentech USA, Inc.$58
- Seagen Inc.$29
- Takeda Pharmaceuticals U.S.A., Inc.$22
- plus $70 from 5 others
What the payments were for
- Food & beverage$971100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Siemens Medical Solutions USA, Inc. | 10 | $520 |
| Abbott | 3 | $149 |
| Daiichi Sankyo Inc. | 1 | $123 |
| Genentech USA, Inc. | 3 | $58 |
| Seagen Inc. | 2 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Johnson & Johnson | 1 | $20 |
| Beckman Coulter, Inc. | 1 | $18 |
| Amgen | 1 | $14 |
| Jazz Pharmaceuticals Inc. | 1 | $12 |
| Sysmex America, Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Atellica IM 1300 Analyzer$131
- Atellica CH 930 Analyzer$131
- RAPIDPoint 500e Blood Gas System$126
- INJECTAFER$123
- Alinity$117
How this compares
$971 in reported general payments places this provider in the 85th percentile of 736 anatomic pathology & clinical pathology providers in Texas.
See all anatomic pathology & clinical pathology providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anatomic pathology & clinical pathology in Lubbock
- Samantha NgamsuntikulSan Antonio$3.2M
- Eric SalazarHouston$1.2M
- Christopher BibbBryan$1.1M
- Rachel-Louise BeddardSan Antonio$809K
- Aamir EhsanSan Antonio$601K
- Rabia ShafiHouston$519K
- Robert BradyFort Sam Houston$479K
- Hesham AminHouston$429K
- Scott LloydTyler$388K
- Shady El-ZayatyDallas$286K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.